Human susceptibility to coronary artery disease: lessons from chimpanzee resilience
Authors:
- 29 June 2022
- journal article
- editorial
- Published by Springer Nature in Nature Reviews Cardiology
- Vol. 19 (8) , 497-498
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Mortality in STEMI patients without standard modifiable risk factors: a sex-disaggregated analysis of SWEDEHEART registry dataThe Lancet, 2021
- A decade of genome-wide association studies for coronary artery disease: the challenges aheadCardiovascular Research, 2018
- Increasing proportion of ST elevation myocardial infarction patients with coronary atherosclerosis poorly explained by standard modifiable risk factorsEuropean Journal of Preventive Cardiology, 2017
- Loss of CMAH during Human Evolution Primed the Monocyte–Macrophage Lineage toward a More Inflammatory and Phagocytic StateThe Journal of Immunology, 2017
- Relative Over-Reactivity of Human versus Chimpanzee Lymphocytes: Implications for the Human Diseases Associated with Immune ActivationThe Journal of Immunology, 2010
- ORIGINAL ARTICLE: Heart disease is common in humans and chimpanzees, but is caused by different pathological processesEvolutionary Applications, 2009
- Loss of Siglec expression on T lymphocytes during human evolutionProceedings of the National Academy of Sciences, 2006
- Comparing the human and chimpanzee genomes: Searching for needles in a haystackGenome Research, 2005
- The Nonhuman Primates as Models for Studying Human Atherosclerosis: Studies on the Chimpanzee, the Baboon and the Rhesus Macacus1976
- Coronary disease in the apeAmerican Heart Journal, 1942